Get started
JOHNSON & JOHNSONJOHNSON & JOHNSONJOHNSON & JOHNSON

JOHNSON & JOHNSON

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4JNJ trade ideas

JNJ Short Swing OpportunityHere's my thoughts on a JNJ short opportunity that set up this week based on the following: 1) Parallel Channel Failed Breakout 2) Weekly Shooting Star Candlestick 3) Daily Evening Star Candlestick Pattern 4) Daily RSI Divergence 5) Completion of Wave 5 Elliott Pattern Weekly Chart On the weekly chart, there is a failed breakout of parallel channel with a shooting star formed at the end of the week inside the channel. Looking below at the daily chart, the top of the channel is now acting as resistance. Daily Chart On the daily chart, an evening star pattern was completed on Thursday, signaling a reversal in trend. There is also a divergence in RSI. Elliott Wave Still learning Elliott Wave but for the sake of sharing as I learn, it looks to be a completion of Wave 5 at the recent top. Will continue to watch to see the corrective wave pattern setup. Additional Considerations The the talc baby powder lawsuit will affect the stock price once the uncertainty is removed and the settlement is reached. Earnings on 15 Oct. Not financial advice. Do your own research.
NYSE:JNJShort
by Steversons
2
JNJ completing correction wave C NYSE:JNJ JNJ is in multi decade uptrend peaked at 187 – presumably end of major wave 5 and turned into Elliott ABC correction, where major wave (A) length is about 37. Per fibo relation major wave (C) should most probably end at 139.5, while intermediate wave ‘c’ – a unit of the major wave (C) might break the pattern bringing the end of correction to 133 and beyond until possible exhaustion of the major correction at higher fibo multiples. At the same time the stock is trading in a downward channel with a lower bound standing now at 141, as well as built-in triangle pattern identifies target as of 137.5 (not very reliable) Week chart: EMA 50 & 200 confirming death cross – it’s late coz in JNJ case SMA 50/200 confirmed it earlier at around 160 – i.e. the stock is already about to be bottomed. RSI in week chart is not yet oversold, while in day chart RSI is heavily oversold. I would consider weekly and daily RSI to align getting both in oversold territory and open long at somewhere 139-141 with a price target being upper boundary of the current downward channel
NYSE:JNJLong
by mike_volk
JNJ Short IdeaThe Dow looks pretty weak right now to me and as we've seen the mag 7 rally relentlessly. I've been avoiding shorts on tech and semis because they are driving the majority of this rally and shorts have not worked. The Dow has been fairly strong, it is near ATH with everything else. However, there have been a lot of bearish stocks in the Dow such as NKE and DIS, which is where I have focused my shorts recently. I think it may be time for tech to weaken, but it looks like the Dow will as well. NKE and DIS are a bit too low for me to want to short, but I think there's still some good opportunities on stocks like JNJ. This is a shorter term time frame, but if you zoom out you can see that the ascending trendline shown above, goes back to a major uptrend from 2016. It recently rejected off that trendline and the descending one above. I'd say it's quite bearish to see a break below and rejection of a 10 year trend. I expect downside to continue here for a good while, unless the Dow can hold up and remain strong.
NYSE:JNJShort
by AdvancedPlays
Johnson & Johnson (JNJ) - Approaching the Reversal ZoneIn April, we anticipated a pullback for JNJ, and since then, the stock has dropped approximately 7%, aligning with our expectations. The current trend suggests further downward movement, reinforcing our previous analysis. We are focusing on the support zone ranging from $134 to $116, with a potential lower bound at $109, the Corona-Low. The ongoing pullback could represent the completion of Wave (4) within this target zone, aligning with multiple levels. We are going to be monitoring this for signs of a reversal within this zone. This zone will be crucial to confirm the next possible upward movement.
NYSE:JNJLong
by freeguy_by_wmc
1
Ichimoku Watch: Johnson & Johnson Eyeing Possible Breakout Upcoming Earnings: Johnson & Johnson (ticker: JNJ) is scheduled to report earnings before the market opens today. The consensus Earnings Per Share (EPS) estimate for the fiscal quarter ending June 2024 is $2.71. The reported EPS for the same quarter last year was $2.80. Breakout Above Cloud? The daily chart of Johnson & Johnson shows that this stock has been working with a downtrend since forging an all-time high of $186.69. However, price has struggled to get through $145.00 support since October 2023 and we have recently seen price drive into the upper boundary of the Ichimoku Cloud, made up of the Leading Span B (light orange at $149.30) and the Leading Span A (light green at $147.60). A price break above the upper limit of the Ichimoku Cloud would be considered a bullish signal. Adding weight to a possible move higher is the Conversion Line (blue at $147.80) crossing above the Base Line (red at $147.50) on 11 July, and price movement trading below its Lagging Span (green at $151.01). Price Direction? With the Ichimoku Indicator suggesting a possible breakout higher beyond the Ichimoku Cloud, this could trigger a wave of follow-through buying towards the May top of $154.86.
NYSE:JNJLong
by FPMarkets
Johnson & Johnson Downtrend Line Breakout at $148.9 17.07.2024- Johnson & Johnson chart shows a downtrendline breakout at $148.95 - If breakout holds, price could rally to $152.00; if $152.00 is breached, target $154.40. - If breakout fails, price may drop to $145.06; if $145.06 is breached, target $140.12. Apply risk management Risk Warning: Trading in CFDs is highly speculative and carries a high level of risk. It is possible to lose all of your invested capital. These products may not be suitable for everyone, and you should ensure that you fully understand the risks taking into consideration your investment objectives, level of experience, personal circumstances as well as personal resources. Speculate only with funds that you can afford to lose. Seek independent advice if necessary. Please refer to our Risk Disclosure. BDSwiss is a trading name of BDS Markets and BDS Ltd. BDS Markets is a company incorporated under the laws of the Republic of Mauritius and is authorized and regulated by the Financial Services Commission of Mauritius ( FSC ) under license number C116016172, address: 6th Floor, Tower 1, Nexteracom Building 72201 Ebene. BDS Ltd is authorized and regulated by the Financial Services Authority Seychelles (FSA) under license number SD047, address: Suite 3, Global Village, Jivan’s Complex, Mont Fleuri, Mahe, Seychelles. Payment transactions are managed by BDS Markets (Registration number: 143350) Disclaimer
NYSE:JNJLong
by Stuart_Cowell
JNJ impending shortThe chart illustrates the possibility of a correction down to a major trend line. This would mean millions of dollars lost in market cap within the next several months or years. If the movement is drastic we may see the company attempt perform countermeasures to provide shareholders a soft landing. One of these countermeasures could be (which I think will be more than likely) layoffs, or termination of complete organizations within the company. As technology advances and consumers of JNJ products increase in cost, the company may pivot to less expensive methods of operations. Attrition is a key variable that I foresee in the near future which could help the company regain some stability in the market. Many people will lose their jobs, but shareholder interest is at the forefront of any good company. Skills are easy to obtain nowadays but public moral is probably at an all time low or leveled with 1950s Vietnam era. If people are unmotivated to learn, they will contribute to the overall downturn of the economy.
NYSE:JNJShort
by EJSM
J&J Entangled in Talc-Related Lawsuits and Bankruptcy AllegationCore Issues: * J&J faces numerous lawsuits alleging its talc products contain asbestos and cause cancer. * The company's utilization of a "Texas two-step" bankruptcy strategy to shield assets from litigation has drawn accusations of fraud. Recent Developments: * Cancer victims filed a class action lawsuit on May 22nd, 2024, alleging J&J's fraudulent use of bankruptcy and asset transfers to avoid compensation. * J&J maintains the safety of its talc and claims the lawsuit disrupts their proposed settlement plan. Broader Implications: * This legal battle raises concerns about potential abuses of bankruptcy laws by corporations seeking to evade product liability. * The case has significant financial ramifications for J&J, with analysts citing negative impacts on stock valuation. Conclusion: * The outcome of these lawsuits will determine compensation for victims, J&J's future financial liabilities, and potentially set precedents for corporate responses to mass tort claims. * Upcoming developments, such as the claimant's vote on the settlement and the court's response to the latest bankruptcy filing, will be crucial in resolving this protracted dispute.
NYSE:JNJShort
by signalmastermind